Targeting Alzheimer’s disease with a Geroscience approach
The drug cocktail of acarbose/rapamycin/phenylbutyrate reduced the negative effects of hippocampal amyloid and tau pathology on two measures of cognitive function.
Authors
- Martin Darvas (ORCID: https://orcid.org/0000-0002-7942-2526)
Institutions
- University of Washington (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.093259
- Primary Topic
- Nutrition, Genetics, and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00